Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

SEC filing history

Showing 451-475 of 798 matching filings.

Per page
25
Current page
19
4

PRIMARY DOCUMENT

Filing date
13 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
13 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
10 Dec 2018
Reporting date
05 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-227209

FORM S-3ASR

Filing date
06 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Aug 2018
Reporting date
23 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35921

CT ORDER filing

Filing date
21 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-35921

10-Q

Filing date
20 Aug 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

FORM 8-K

Filing date
07 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
01 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Jul 2018
Reporting date
16 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jun 2018
Reporting date
26 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MIRATI THERAPEUTICS, INC.

Filing date
12 Jun 2018
Reporting date
11 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jun 2018
Reporting date
07 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
07 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207848

424B5

Filing date
07 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207848

424B5

Filing date
06 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
07 May 2018
Reporting date
07 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Apr 2018
Reporting date
25 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .